Stocks · News reference
This Atlassian Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Top Wall Street analysts changed outlook on top names. See analyst ratings page for all changes. Consider ACMR stock: analysts' thoughts
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Buy These 5 Semiconductor Stocks as Sales Skyrocket on Solid AI Demand
Global semiconductor sales reached $146.8 billion in July, up 6.4% sequentially and 135.1% year-over-year, marking 17 consecutive months of growth. Driven by strong AI demand and robust earnings from major chip companies, five semiconductor stocks are recommended as attractive investment opportunities with significant growth potential.
Shares of semiconductor and chip companies are trading higher. The broader industry may be rallying alongside memory and storage-related peers.
Shares of semiconductor and chip companies are trading lower, possibly after Federal Reserve Chairman Warsh's comments on inflation and prices raised rate-hike concerns. The sector may be facing pressure from peer Marvell Technology, as the company pulls back after its FY28 guidance may have failed to meet investor expectations.
8-K filing — Evommune, Inc. (EVMN)
Filed: 2026-09-15 AccNo: 0001193125-26-391390 Size: 18 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Leerink Partners Maintains Outperform on Evommune, Lowers Price Target to $22
Leerink Partners analyst Thomas Smith maintains Evommune (NYSE:EVMN) with a Outperform and lowers the price target from $28 to $22.